ATE204851T1 - Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten - Google Patents
Verfahren zur herstellung von retrovial protease hemmenden zwischenproduktenInfo
- Publication number
- ATE204851T1 ATE204851T1 AT96903641T AT96903641T ATE204851T1 AT E204851 T1 ATE204851 T1 AT E204851T1 AT 96903641 T AT96903641 T AT 96903641T AT 96903641 T AT96903641 T AT 96903641T AT E204851 T1 ATE204851 T1 AT E204851T1
- Authority
- AT
- Austria
- Prior art keywords
- protease
- retrovial
- producing
- intermediate products
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/18—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with hydroxy groups and at least two amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/26—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/376,340 US5831117A (en) | 1995-01-20 | 1995-01-20 | Method of preparing retroviral protease inhibitor intermediates |
PCT/US1996/000918 WO1996022275A1 (en) | 1995-01-20 | 1996-01-18 | Method of preparing retroviral protease inhibitor intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE204851T1 true ATE204851T1 (de) | 2001-09-15 |
Family
ID=23484633
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96903641T ATE204851T1 (de) | 1995-01-20 | 1996-01-18 | Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten |
Country Status (16)
Country | Link |
---|---|
US (7) | US5831117A (de) |
EP (1) | EP0804410B1 (de) |
JP (1) | JP3978229B2 (de) |
KR (1) | KR100385013B1 (de) |
CN (1) | CN1623977A (de) |
AT (1) | ATE204851T1 (de) |
AU (1) | AU692062B2 (de) |
BR (1) | BR9606981A (de) |
CA (1) | CA2210973C (de) |
DE (1) | DE69614824T2 (de) |
DK (1) | DK0804410T3 (de) |
ES (1) | ES2162650T3 (de) |
HU (1) | HUP9702403A3 (de) |
NZ (1) | NZ302072A (de) |
PT (1) | PT804410E (de) |
WO (1) | WO1996022275A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5831117A (en) * | 1995-01-20 | 1998-11-03 | G. D. Searle & Co. | Method of preparing retroviral protease inhibitor intermediates |
DE60124080T2 (de) | 2000-03-23 | 2007-03-01 | Elan Pharmaceuticals, Inc., San Francisco | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
US6992081B2 (en) | 2000-03-23 | 2006-01-31 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
EP1666452A2 (de) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Verbindungen zur Behandlung der Alzheimerischen Krankheit |
PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
CN1217920C (zh) | 2000-06-30 | 2005-09-07 | 艾兰制药公司 | 治疗早老性痴呆的化合物 |
US20030096864A1 (en) * | 2000-06-30 | 2003-05-22 | Fang Lawrence Y. | Compounds to treat alzheimer's disease |
BR0210721A (pt) | 2001-06-27 | 2004-07-20 | Elan Pharm Inc | Composto, sal ou éster farmaceuticamente aceitável, método para fabricar um composto, e, método para tratar um paciente que tem, ou para evitar que o paciente adquira uma doença ou condição |
US20070213407A1 (en) * | 2001-06-29 | 2007-09-13 | Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc | Compounds to treat Alzheimer's disease |
US6867302B2 (en) * | 2001-07-13 | 2005-03-15 | Board Of Trustees Of Michigan State University | Process for the catalytic synthesis of biaryls and polymers from aryl compounds |
ATE443043T1 (de) | 2002-11-12 | 2009-10-15 | Merck & Co Inc | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer |
TWI385173B (zh) | 2005-11-28 | 2013-02-11 | Tibotec Pharm Ltd | 作為hiv蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物 |
CN102099331A (zh) * | 2008-05-19 | 2011-06-15 | 杏林制药株式会社 | 光学活性氨基醇衍生物的制备方法 |
CN116675613B (zh) * | 2023-08-03 | 2023-10-10 | 北京元延医药科技股份有限公司 | 手性拆分制备重酒石酸去甲肾上腺素的方法 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4268688A (en) | 1973-02-16 | 1981-05-19 | Monsanto Company | Asymmetric hydroformylation process |
JPS5825677B2 (ja) | 1977-09-26 | 1983-05-28 | 武田薬品工業株式会社 | 3−テトラゾ−ル−1−アザキサントン誘導体およびその製造法 |
US5142056A (en) | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US4477414A (en) | 1981-05-20 | 1984-10-16 | Fumakilla Limited | Evaporative container |
EP0068378B1 (de) * | 1981-06-26 | 1986-03-05 | Schering Corporation | Imidazo(1,2-a)pyridine und -pyrazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
EP0104041B1 (de) | 1982-09-15 | 1988-07-27 | Aktiebolaget Hässle | Enzyminhibitoren |
US4668770A (en) | 1982-12-27 | 1987-05-26 | Merck & Co., Inc. | Renin inhibitory tripeptides |
WO1984003044A1 (en) | 1983-02-07 | 1984-08-16 | Ferring Ab | Enzyme inhibitors |
JPS59227851A (ja) | 1983-06-09 | 1984-12-21 | Sankyo Co Ltd | レニン阻害作用を有するペプチド類 |
US4514391A (en) | 1983-07-21 | 1985-04-30 | E. R. Squibb & Sons, Inc. | Hydroxy substituted peptide compounds |
US4477441A (en) | 1983-09-14 | 1984-10-16 | Merck & Co., Inc. | Renin inhibitors containing a C-terminal disulfide cycle |
US4645759A (en) | 1984-06-22 | 1987-02-24 | Abbott Laboratories | Renin inhibiting compounds |
US4749792A (en) * | 1984-09-26 | 1988-06-07 | E. R. Squibb & Sons, Inc. | Diamino ketones and alcohols as analgesic agents |
US4616088A (en) | 1984-10-29 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitor |
CN1003504B (zh) | 1984-12-03 | 1989-03-08 | 三井东圧化学有限公司 | 氯气制备方法 |
US4826815A (en) * | 1985-05-17 | 1989-05-02 | Abbott Laboratories | Renin inhibiting compounds |
US4599198A (en) | 1985-08-02 | 1986-07-08 | Pfizer Inc. | Intermediates in polypeptide synthesis |
US4668769A (en) | 1985-08-02 | 1987-05-26 | Hoover Dennis J | Oxa- and azahomocyclostatine polypeptides |
CA1282549C (en) | 1985-11-12 | 1991-04-02 | Eric M. Gordon | Aminocarbonyl renin inhibitors |
US4757050A (en) | 1985-12-23 | 1988-07-12 | E. R. Squibb Sons, Inc. | Ureido renin inhibitors |
CA1297631C (en) | 1985-12-23 | 1992-03-17 | Sesha I. Natarajan | Ureido renin inhibitors |
US4857507A (en) * | 1986-04-11 | 1989-08-15 | Abbott Laboratories | Angiotensinogen analogs |
US4880938A (en) * | 1986-06-16 | 1989-11-14 | Merck & Co., Inc. | Amino acid analogs |
DE3635907A1 (de) | 1986-10-22 | 1988-04-28 | Merck Patent Gmbh | Hydroxy-aminosaeurederivate |
DE3800591A1 (de) | 1987-01-21 | 1988-08-04 | Sandoz Ag | Neue peptidderivate, ihre herstellung und verwendung |
GB2200115B (en) * | 1987-01-21 | 1990-11-14 | Sandoz Ltd | Novel peptide derivatives, their production and use |
USH725H (en) | 1987-02-26 | 1990-01-02 | E. R. Squibb & Sons, Inc. | Ureido amino and imino acids, compositions and methods for use |
GB8707412D0 (en) | 1987-03-27 | 1987-04-29 | Fujisawa Pharmaceutical Co | Peptide compounds |
DE3711911A1 (de) | 1987-04-08 | 1988-10-20 | Bayer Ag | Optisch aktive (alpha)-aminoaldehyde, verfahren zu ihrer herstellung und ihre verwendung zur stereoselektiven herstellung optisch aktiver ss-aminoalkohole |
DE3830825A1 (de) | 1987-09-15 | 1989-03-23 | Sandoz Ag | Hydrophile reninhemmer, ihre herstellung und verwendung |
DE3800059A1 (de) * | 1988-01-04 | 1989-07-13 | Paul Merkle | Modulo-10-zaehler fuer beide zaehl-richtungen |
IL89900A0 (en) | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
US4977277A (en) | 1988-05-09 | 1990-12-11 | Abbott Laboratories | Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof |
IL90218A0 (en) | 1988-05-13 | 1989-12-15 | Abbott Lab | Retroviral protease inhibitors |
CA1340588C (en) | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
IL91307A0 (en) | 1988-08-24 | 1990-03-19 | Merck & Co Inc | Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them |
CA2012306A1 (en) | 1989-03-28 | 1990-09-28 | Werner Neidhart | Amino acid derivatives |
DE3912829A1 (de) | 1989-04-19 | 1990-10-25 | Bayer Ag | Verwendung von renininhibitorischen peptiden als mittel gegen retroviren |
TW225540B (de) | 1990-06-28 | 1994-06-21 | Shionogi & Co | |
EP0538366A1 (de) | 1990-07-06 | 1993-04-28 | Smithkline Beecham Corporation | Retrovirale protease inhibitoren |
ATE164839T1 (de) * | 1990-11-19 | 1998-04-15 | Monsanto Co | Retrovirale proteaseinhibitoren |
DK0641333T3 (da) | 1992-05-20 | 1996-09-02 | Monsanto Co | Fremgangsmåde til fremstilling af mellemprodukter, som er anvendelige ved syntese af retrovirus- protease-inhibitorer |
KR100336699B1 (ko) | 1992-08-25 | 2002-05-13 | 윌리암스 로저 에이 | 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드 |
IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
ES2061380B1 (es) | 1992-11-23 | 1995-07-01 | Boehringer Ingelheim Espana | Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores. |
US5484926A (en) * | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5514801A (en) * | 1992-12-29 | 1996-05-07 | Monsanto Company | Cyclic sulfone containing retroviral protease inhibitors |
ATE172970T1 (de) * | 1993-07-15 | 1998-11-15 | Hoffmann La Roche | Verfahren zur herstellung eines n-tert.butylamids |
DK0855388T3 (da) * | 1993-11-23 | 2002-04-29 | Searle & Co | Fremgangsmåde til fremstilling af mellemprodukter, der kan anvendes til syntese af retrovirale proteaseinhibitorer |
JP2996459B2 (ja) * | 1994-07-14 | 1999-12-27 | ダイワ精工株式会社 | ゴルフクラブヘッド |
US5831117A (en) * | 1995-01-20 | 1998-11-03 | G. D. Searle & Co. | Method of preparing retroviral protease inhibitor intermediates |
DE60115194T2 (de) * | 2000-07-19 | 2006-08-10 | Tokuyama Corp., Shunan | Photohärtbares material für zahnreparaturen |
AU2003234498A1 (en) | 2002-05-03 | 2003-11-17 | Stowers Institute For Medical Research | Method for predicting gene potential and cell commitment |
-
1995
- 1995-01-20 US US08/376,340 patent/US5831117A/en not_active Expired - Fee Related
-
1996
- 1996-01-18 NZ NZ302072A patent/NZ302072A/xx unknown
- 1996-01-18 AU AU47653/96A patent/AU692062B2/en not_active Ceased
- 1996-01-18 ES ES96903641T patent/ES2162650T3/es not_active Expired - Lifetime
- 1996-01-18 CA CA002210973A patent/CA2210973C/en not_active Expired - Fee Related
- 1996-01-18 KR KR1019970704936A patent/KR100385013B1/ko not_active IP Right Cessation
- 1996-01-18 DK DK96903641T patent/DK0804410T3/da active
- 1996-01-18 HU HU9702403A patent/HUP9702403A3/hu active IP Right Revival
- 1996-01-18 AT AT96903641T patent/ATE204851T1/de not_active IP Right Cessation
- 1996-01-18 EP EP96903641A patent/EP0804410B1/de not_active Expired - Lifetime
- 1996-01-18 BR BR9606981A patent/BR9606981A/pt not_active IP Right Cessation
- 1996-01-18 CN CNA2004100560283A patent/CN1623977A/zh active Pending
- 1996-01-18 DE DE69614824T patent/DE69614824T2/de not_active Expired - Fee Related
- 1996-01-18 PT PT96903641T patent/PT804410E/pt unknown
- 1996-01-18 WO PCT/US1996/000918 patent/WO1996022275A1/en active IP Right Grant
- 1996-01-18 JP JP52244296A patent/JP3978229B2/ja not_active Expired - Lifetime
-
1998
- 1998-02-17 US US09/024,662 patent/US6201150B1/en not_active Expired - Fee Related
-
2000
- 2000-12-21 US US09/741,087 patent/US6515162B2/en not_active Expired - Fee Related
-
2002
- 2002-12-23 US US10/325,952 patent/US6849760B2/en not_active Expired - Fee Related
-
2004
- 2004-10-12 US US10/961,405 patent/US7060851B2/en not_active Expired - Fee Related
-
2006
- 2006-05-16 US US11/434,509 patent/US20060270855A1/en not_active Abandoned
- 2006-07-05 US US11/480,586 patent/US20070015818A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20010047111A1 (en) | 2001-11-29 |
NZ302072A (en) | 1999-01-28 |
EP0804410B1 (de) | 2001-08-29 |
HUP9702403A3 (en) | 1999-10-28 |
DK0804410T3 (da) | 2001-11-26 |
US5831117A (en) | 1998-11-03 |
ES2162650T3 (es) | 2002-01-01 |
AU4765396A (en) | 1996-08-07 |
CN1623977A (zh) | 2005-06-08 |
WO1996022275A1 (en) | 1996-07-25 |
US6201150B1 (en) | 2001-03-13 |
DE69614824D1 (de) | 2001-10-04 |
JPH10512571A (ja) | 1998-12-02 |
US20030171612A1 (en) | 2003-09-11 |
BR9606981A (pt) | 1997-11-04 |
PT804410E (pt) | 2002-01-30 |
US6515162B2 (en) | 2003-02-04 |
HUP9702403A2 (hu) | 1999-09-28 |
KR100385013B1 (ko) | 2003-08-19 |
EP0804410A1 (de) | 1997-11-05 |
US7060851B2 (en) | 2006-06-13 |
JP3978229B2 (ja) | 2007-09-19 |
DE69614824T2 (de) | 2002-04-11 |
CA2210973A1 (en) | 1996-07-25 |
KR19980701545A (ko) | 1998-05-15 |
US20070015818A1 (en) | 2007-01-18 |
US6849760B2 (en) | 2005-02-01 |
CA2210973C (en) | 2007-08-07 |
US20060270855A1 (en) | 2006-11-30 |
US20050131075A1 (en) | 2005-06-16 |
AU692062B2 (en) | 1998-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE148113T1 (de) | Retrovirale protease inhibitoren, enthaltend cyclische sulfone | |
ATE204851T1 (de) | Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten | |
ATE283264T1 (de) | Zwischenprodukte zur herstellung von metallproteinasehemmern | |
ATE215062T1 (de) | Verfahren zur herstellung von cyclohexen- carboxylatderivate | |
DE60320362D1 (de) | Verfahren zur Herstellung von Dipeptiden | |
ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
BR9807936A (pt) | Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação | |
DE69927602D1 (de) | Verfahren zur herstellung von vitaminpulvern | |
ATE270275T1 (de) | Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren | |
ATE404674T1 (de) | Verfahren zur herstellung von ergosterol und dessen zwischenprodukten mittels rekombinanter hefen | |
DE69300551D1 (de) | Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid. | |
ATE281434T1 (de) | Verfahren zur herstellung von benzoperhydroisoindolen | |
DE69614899D1 (de) | Verfahren zur Herstellung von Aryl-alkyl-hydroperoxiden | |
ATE346084T1 (de) | Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga | |
ATE325794T1 (de) | Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin | |
PT633928E (pt) | Microrganismos processo de preparacao e utilizacao | |
BG98888A (en) | Method for the preparation of 3-acylestratrienes and acylbezenes | |
DE59802620D1 (de) | Verfahren zur Herstellung von trans-(R,R)-Actinol | |
DE69603163D1 (de) | VERFAHREN ZUR HERSTELLUNG VON HIV PROTEASE INHIBITOR AUSGEHEND VON (2S)-4-PICOLYL-2-PIPERAZIN-t-BUTYLCARBOXAMID | |
DE59808476D1 (de) | VERFAHREN ZUR HERSTELLUNG VON ARZNEIMITTELN, ENTHALTEND HMG-CoA- REDUKTASEINHIBITOREN | |
DE59405085D1 (de) | Verfahren zur Herstellung von Tetrachlor-1,4-benzochinon | |
ATE361913T1 (de) | Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren | |
DE69927247D1 (de) | Verfahren zur herstellung von fleischprodukten | |
DE69718690D1 (de) | Verfahren zur Herstellung von optisch-aktivem 2-halogen-1-(substituiertes Phenyl)ethanol. | |
DE50206615D1 (de) | Verfahren zur Herstellung von 15-Pentadecanolid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |